Osprey Medical gets FDA OK for angiogram device

08/26/2013 | BioSpectrum Asia

Osprey Medical has been cleared by the FDA to market its Avert System, which is used to minimize patient exposure to dye during angiogram or diagnostic heart procedures. A clinical study showed the device was able to lower by as much as 40% the amount of dye used during angiograms while maintaining image quality.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA